UnitedHealth (UNH) Gets a Buy From Oppenheimer
Positive Growth Trajectory and Robust Financial Health Reinforce Buy Rating for UnitedHealth
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $655
George Hill's Buy Rating on UnitedHealth Driven by Investor Conference Insights and Optimistic 2025 Revenue Projections
Argus Adjusts Price Target on UnitedHealth Group to $670 From $600
UnitedHealth Is Maintained at Overweight by Stephens & Co.
UnitedHealth Group Analyst Ratings
Deutsche Bank raised the target price of UnitedHealth to $625.
UnitedHealth Is Maintained at Buy by Deutsche Bank
Deutsche Bank Raises Price Target on UnitedHealth Group to $625 From $595
Barclays raised UnitedHealth's target price to $655.
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
UnitedHealth's Strategic Outlook Reinforces Buy Rating Amidst Positive Medicare Insights and Growth Visibility
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $677